-Designing clinical trials with robust endpoints, appropriate patient stratification, and innovative trial designs, such as adaptive or platform trials, to accelerate the translation of promising therapies to patients. While significant challenges remain, continued research efforts hold promise for advancing our understanding of polyQ diseases and developing effective treatments to improve patients' quality of life and prognosis.